Chronic cyanidin-3-glucoside administration improves short-term spatial recognition memory but not passive avoidance learning and memory in streptozotocin-diabetic rats

Phytotherapy Research

Volumn 26, Issue 8, 2012, Pages 1205-1210

  Nasri, Sima ^a   Roghani, Mehrdad ^b   Baluchnejadmojarad, Tourandokht ^c   Balvardi, Mahboubeh ^a   Rabani, Tahereh ^a  

^a PAYAME NOOR UNIVERSITY   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cyanidin 3 glucoside; diabetic rat; learning and memory; spatial recognition memory

Indexed keywords

CYANIDIN 3 GLUCOSIDE; GLUCOSE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BRAIN TISSUE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LEARNING; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; RAT; RECALL; SHORT TERM MEMORY; SPATIAL MEMORY; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; ANTHOCYANINS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; GLUCOSIDES; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY, SHORT-TERM; MENTAL RECALL; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); SPATIAL BEHAVIOR; STREPTOZOCIN;

RATTUS; RATTUS NORVEGICUS;

EID: 84864219754     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3702     Document Type: Article

References (53)

1. Acquaviv R, Russo A, Galvano F, et al,. 2003. Cyanidin and cyanidin 3-O-beta-D-glucoside as DN cleavage protectors and antioxidants. Cell Biol Toxicol 19: 243-252.
2. Andres-Lacuev C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA,. 2005. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8: 111-120.
3. Baluchnejadmojarad T, Roghani M,. 2006. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: behavioral analysis. Pharmacology 78: 193-197.
4. Baluchnejadmojarad T, Roghani M,. 2011. Chronic epigallocatechin-3- gallate ameliorates learning and memory deficits in diabetic rats vi modulation of nitric oxide and oxidative stress. Behav Brain Res 224: 305-310.
5. Baluchnejadmojarad T, Roghani M, Nadoushan MR, Bagheri M,. 2009. Neuroprotective effect of genistein in 6-hydroxydopamine Hemi-parkinsonian rat model. Phytother Res 23: 132-135.
6. Barros DM, Pereir P, Medin JH, Izquierdo I,. 2002. Modulation of working memory and of long- but not short-term memory by cholinergic mechanisms in the basolateral amygdale. Behav Pharmacol 13: 163-167.
7. Biessels GJ, Kerssen A, de Haan EH, Kappelle LJ,. 2007. Cognitive dysfunction and diabetes: implications for primary care. Prim Care Diabetes 1: 187-193.
8. Bradford MM,. 1976. rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
9. Brands AMA, Biessels GJ, De Haan EHF, Kappelle LJ, Kessels RPC,. 2005. The effects of type 1 diabetes on cognitive performance: meta-analysis. Diabetes Care 28: 726-735.
10. Carlsson CM,. 2010. Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers Dis 20: 711-722.
11. Choi MJ, Kim BK, Park KY, Yokozaw T, Song YO, Cho EJ,. 2010. Anti-aging effects of cyanidin under stress-induced premature senescence cellular system. Biol Pharm Bull 33: 421-426.
12. Dreiseitel A, Korte G, Schreier P, et al,. 2009. sPhospholipase A(2) is inhibited by anthocyanidins. J Neural Transm 116: 1071-1077.
13. El Mohsen MA, Marks J, Kuhnle G, et al,. 2006. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 95: 51-58.
14. Elisi I, Kitts DD,. 2008. Anthocyanins inhibit peroxyl radical-induced apoptosis in Caco-2 cells. Mol Cell Biochem 312: 139-145.
15. Fari A, Pestan D, Teixeir D, et al,. 2010. Flavonoid transport across RBE4 cells: blood-brain barrier model. Cell Mol Biol Lett 15: 234-241.
16. Fukui K, Omoi NO, Hayasak T, Shinnkai T, Suzuki S, Abe K, Urano S,. 2002. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann N Y Acad Sci 959: 275-284.
17. Hawkins CL, Davies MJ,. 2001. Generation and propagation of radical reactions on proteins. Biochim Biophys Act 504: 196-219.
18. Izquierdo I, Medin JH, Izquierdo LA, Barros DM, de Souz MM, Mello e Souz T. 1998. Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiol Learn Mem 69: 219-224.
19. Iwai T, Suzuki M, Kobayashi K, Mori K, Mogi Y, Ok J,. 2009. The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1. Neurosci Res 64: 67-74.
20. Jin HY, Liu WJ, Park JH, Baek HS, Park TS,. 2009. Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Arch Med Res 40: 536-544.
21. Kucukatay V, AÄar A, Gumuslu S, YargiçoÄlu P,. 2007. Effect of sulfur dioxide on active and passive avoidance in experimental diabetes mellitus: relation to oxidant stress and antioxidant enzymes. Int J Neurosci 117: 1091-1107.
22. Laight DW, Carrier MJ, Anggard EE,. 2000. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47: 457-464.
23. Li ZG, Zhang W, Grunberger G, Sim AA,. 2002. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946: 221-231.
24. Manschot SM, Biessels GJ, Rutten GE, et al,. 2008. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J Neurol Sci 264: 157-162.
25. Marczylo TH, Cooke D, Brown K, Steward WP, Gescher AJ,. 2009. Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice. Cancer Chemother Pharmacol 64: 1261-1268.
26. Matsui T, Ebuchi S, Kobayashi M, et al,. 2002. Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoe batatas cultivar Ayamurasaki can be achieved through the alpha-glucosidase inhibitory action. J Agric Food Chem 50: 7244-7248.
27. Mertens-Talcott SU, Rios J, Jilma-Stohlawetz P, et al,. 2008. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe olerace Mart.) in human healthy volunteers. J Agric Food Chem 56: 7796-7802.
28. Mulabagal V, Lang GA, DeWitt DL, Dalavoy SS, Nair MG,. 2009. Anthocyanin content, lipid peroxidation and cyclooxygenase enzyme inhibitory activities of sweet and sour cherries. J Agric Food Chem 57: 1239-1246.
29. Nitt A, Murai R, Suzuki N, et al,. 2002. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol 24: 695-701.
30. Nod Y, Kaneyuki T, Mori A, Packer L,. 2002. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem 50: 166-171.
31. Patil CS, Singh VP, Kulkarni SK,. 2006. Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacol Rep 58: 373-380.
32. Ramirez MR, Izquierdo I, do Carmo Bassols Raseir M, Zuanazzi JA, Barros D, Henriques AT,. 2005. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52: 457-462.
33. Rasoolijazi H, Joghataie MT, Roghani M, Nobakht M,. 2007. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: behavioral analysis. Iran Biomed J 11: 237-243.
34. Rhee SJ, Jeong YC, Choi JH,. 2005. Effects of vitamin E on phospholipase A2 activity and oxidative damage to the liver in streptozotocin-induced diabetic rats. Ann Nutr Metab 49: 392-396.
35. Roghani M, Baluchnejadmojarad T,. 2009. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul Pharmacol 51: 84-89.
36. Roriz-Filho J, Sá-Roriz TM, Rosset I, et al,. 2009. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Act 1792: 432-443.
37. Sanchez-Meji RO, Newman JW, Toh S, et al,. 2008. Phospholipase A2 reduction ameliorates cognitive deficits in mouse model of Alzheimer's disease. Nat Neurosci 11: 1311-1318.
38. Sasaki R, Nishimur N, Hoshino H, et al,. 2007. Cyanidin 3-glucoside ameliorates hyperglycemi and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol 74: 1619-1627.
39. Schroeter H, Boyd C, Spencer JP, Williams RJ, Cadenas E, Rice-Evans C,. 2002. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23: 861-880.
40. Stewart R, Liolits D,. 1999. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16: 93-112.
41. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP,. 2008b. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 11: 309-317.
42. Stranahan AM, Lee K, Pistell PJ, et al,. 2008a. Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels. Neurobiol Learn Mem 90: 479-483.
43. Tarozzi A, Merlicco A, Morroni F, et al,. 2008. Cyanidin 3-O-glucopyranoside protects and rescues SH-SY5Y cells against amyloid-bet peptide-induced toxicity. Neuroreport 19: 1483-1486.
44. Tarozzi A, Morroni F, Merlicco A, et al,. 2010. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid bet (25-35) oligomer-induced toxicity. Neurosci Lett 473: 72-76.
45. Tsud T, Horio F, Uchid K, Aoki H, Osaw T,. 2003. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemi in mice. J Nutr 133: 2125-2130.
46. Tuzcu M, Baydas G,. 2006. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 537: 106-110.
47. Van Deutekom AW, Niessen HW, Schalkwijk CG, Heine RJ, Simsek S,. 2008. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in (streptozotocin-treated) rat model of diabetes mellitus. Eur J Endocrinol 158: 655-660.
48. Wang Q, Xi M, Liu C, et al,. 2008. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alph activation in THP-1 macrophages. Life Sci 83: 176-184.
49. Wrighten SA, Piroli GG, Grillo CA, Reagan LP,. 2009. look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Act 1792: 444-453.
50. Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL,. 2011. Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem 11: 169-177.
51. Xu JW, Iked K, Yamori Y,. 2004. Cyanidin-3-glucoside regulates phosphorylation of endothelial nitric oxide synthase. FEBS Lett 574: 176-180.
52. Yao Y, Vieir A,. 2007. Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity. Neurotoxicology 28: 93-100.
53. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ,. 2004. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36: 592-604.